Literature DB >> 33711132

Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study.

R I Troisi1,2, G Berardi1,2,3, Z Morise4, F Cipriani5, S Ariizumi6, C Sposito7, V Panetta8, I Simonelli8, S Kim9, B K P Goh10, S Kubo11, S Tanaka11, Y Takeda12, G M Ettorre13, N Russolillo14, G C Wilson15, M Cimino16, R Montalti17, M C Giglio1, K Igarashi3, C-Y Chan10, G Torzilli16, T T Cheung18, V Mazzaferro7, H Kaneko19, A Ferrero14, D A Geller15, H-S Han9, A Kanazawa20, G Wakabayashi3, L Aldrighetti5, M Yamamoto6.   

Abstract

BACKGROUND: Laparoscopic liver resection for hepatocellular carcinoma (HCC) in Child-Pugh A cirrhosis has been demonstrated as beneficial. However, the role of laparoscopy in Child-Pugh B cirrhosis is undetermined. The aim of this retrospective cohort study was to compare open and laparoscopic resection for HCC with Child-Pugh B cirrhosis.
METHODS: Data on liver resections were gathered from 17 centres. A 1 : 1 propensity score matching was performed according to 17 predefined variables.
RESULTS: Of 382 available liver resections, 100 laparoscopic and 100 open resections were matched and analysed. The 90-day postoperative mortality rate was similar in open and laparoscopic groups (4.0 versus 2.0 per cent respectively; P = 0.687). Laparoscopy was associated with lower blood loss (median 110 ml versus 400 ml in the open group; P = 0.004), less morbidity (38.0 versus 51.0 per cent respectively; P = 0.041) and fewer major complications (7.0 versus 21.0 per cent; P = 0.010), and ascites was lower on postoperative days 1, 3 and 5. For laparoscopic resections, patients with portal hypertension developed more complications than those without (26 versus 12 per cent respectively; P = 0.002), and patients with a Child-Pugh B9 score had higher morbidity rates than those with B8 and B7 (7 of 8, 10 of 16 and 21 of 76 respectively; P < 0.001). Median hospital stay was 7.5 (range 2-243) days for laparoscopic liver resection and 18 (3-104) days for the open approach (P = 0.058). The 5-year overall survival rate was 47 per cent for open and 65 per cent for laparoscopic resection (P = 0.142). The 5-year disease-free survival rate was 32 and 37 per cent respectively (P = 0.742).
CONCLUSION: Patients without preoperative portal hypertension and Child-Pugh B7 cirrhosis may benefit most from laparoscopic liver surgery.
© The Author(s) 2021. Published by Oxford University Press on behalf of BJS Society Ltd. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2021        PMID: 33711132     DOI: 10.1093/bjs/znaa041

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  10 in total

1.  Minimally invasive liver resection for huge (≥10 cm) tumors: an international multicenter matched cohort study with regression discontinuity analyses.

Authors:  Tan-To Cheung; Xiaoying Wang; Mikhail Efanov; Rong Liu; David Fuks; Gi-Hong Choi; Nicholas L Syn; Charing C Chong; Iswanto Sucandy; Adrian K H Chiow; Marco V Marino; Mikel Gastaca; Jae Hoon Lee; T Peter Kingham; Mathieu D'Hondt; Sung Hoon Choi; Robert P Sutcliffe; Ho-Seong Han; Chung Ngai Tang; Johann Pratschke; Roberto I Troisi; Brian K P Goh
Journal:  Hepatobiliary Surg Nutr       Date:  2021-10       Impact factor: 7.293

2.  The preoperative M2BPGi score predicts operative difficulty and the incidence of postoperative complications in laparoscopic liver resection.

Authors:  Tomokazu Fuji; Toru Kojima; Hiroki Kajioka; Misaki Sakamoto; Ryoya Oka; Tetsuya Katayama; Yuki Narahara; Takefumi Niguma
Journal:  Surg Endosc       Date:  2022-09-29       Impact factor: 3.453

Review 3.  BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.

Authors:  Maria Reig; Alejandro Forner; Jordi Rimola; Joana Ferrer-Fàbrega; Marta Burrel; Ángeles Garcia-Criado; Robin K Kelley; Peter R Galle; Vincenzo Mazzaferro; Riad Salem; Bruno Sangro; Amit G Singal; Arndt Vogel; Josep Fuster; Carmen Ayuso; Jordi Bruix
Journal:  J Hepatol       Date:  2021-11-19       Impact factor: 30.083

Review 4.  Leaping the Boundaries in Laparoscopic Liver Surgery for Hepatocellular Carcinoma.

Authors:  Gianluca Cassese; Ho-Seong Han; Boram Lee; Hae Won Lee; Jai Young Cho; Roberto Troisi
Journal:  Cancers (Basel)       Date:  2022-04-15       Impact factor: 6.575

5.  Trans-arterial positive ICG staining-guided laparoscopic liver watershed resection for hepatocellular carcinoma.

Authors:  Xinye Qian; Wang Hu; Lu Gao; Jingyi Xu; Bo Wang; Jiyong Song; Shizhong Yang; Qian Lu; Lin Zhang; Jun Yan; Jiahong Dong
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

6.  Caudal Approach to Laparoscopic Liver Resection-Conceptual Benefits for Repeated Multimodal Treatment for Hepatocellular Carcinoma and Extended Right Posterior Sectionectomy in the Left Lateral Position.

Authors:  Tomoyoshi Endo; Zenichi Morise; Hidetoshi Katsuno; Kenji Kikuchi; Kazuhiro Matsuo; Yukio Asano; Akihiko Horiguchi
Journal:  Front Oncol       Date:  2022-07-11       Impact factor: 5.738

7.  Preservation of the round ligament to accommodate transient portal hypertension after major hepatectomy.

Authors:  D Koliogiannis; H Nieß; V Koliogiannis; M Ilmer; M Angele; J Werner; M Guba
Journal:  Langenbecks Arch Surg       Date:  2022-06-08       Impact factor: 2.895

Review 8.  New concepts in the treatment of hepatocellular carcinoma.

Authors:  Sabrina Sidali; Eric Trépo; Olivier Sutter; Jean-Charles Nault
Journal:  United European Gastroenterol J       Date:  2022-08-16       Impact factor: 6.866

9.  Influence of Child-Pugh B7 and B8/9 cirrhosis on laparoscopic liver resection for hepatocellular carcinoma: a retrospective cohort study.

Authors:  Yukihiro Watanabe; Masayasu Aikawa; Tomotaka Kato; Kenichiro Takase; Yuichiro Watanabe; Katsuya Okada; Kojun Okamoto; Isamu Koyama
Journal:  Surg Endosc       Date:  2022-10-06       Impact factor: 3.453

10.  Survival analysis between laparoscopic and open hepatectomy for hepatocellular carcinoma: a meta-analysis based on reconstructed time-to-event data.

Authors:  Qiang Sun; Xiangda Zhang; Xueyi Gong; Zhipeng Hu; Qiao Zhang; Weiming He; Xiaojian Chang; Zemin Hu; Yajin Chen
Journal:  Hepatol Int       Date:  2021-07-13       Impact factor: 6.047

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.